Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
TIVC Stock Summary
In the News
Tivic Health Systems, Inc. (TIVC) Q4 2023 Earnings Call Transcript
Tivic Health Systems, Inc. (TIVC) Q4 2023 Earnings Call Transcript
Tivic Health to Report 2023 Year-End Financial Results on March 25th Via Conference Call and Webcast
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”) (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will report its year-end financial results for 2023 via pre-recorded conference call and webcast on Monday, March 25, 2024 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 888-506-0062 International: 973-528-0011 Participant Access Code: 434944 Webcast Link https://www.webcaster4.com/Webc.
Tivic Health Systems, Inc. (TIVC) Reports Q3 Loss, Misses Revenue Estimates
Tivic Health Systems, Inc. (TIVC) came out with a quarterly loss of $1.48 per share versus the Zacks Consensus Estimate of a loss of $7. This compares to loss of $27 per share a year ago.
Why Is Tivic Health (TIVC) Stock Up 63% Today?
Tivic Health (NASDAQ: TIVC ) stock is taking off on Monday as investors are hopeful about the health technology company's upcoming earnings report. Tivic Health is set to release its earnings report for the third quarter of 2023 after markets close on Tuesday.
Why Is Tivic Health Systems (TIVC) Stock Up 112% Today?
Tivic Health Systems (NASDAQ: TIVC ) stock is rocketing higher on Tuesday despite a lack of news this morning. However, one thing that investors will note is the health technology company's shares seeing heavy trading today.
Why Is Tivic Health Systems (TIVC) Stock Up 45% Today?
Tivic Health Systems (NASDAQ: TIVC ) stock is rocketing higher on Thursday after getting started on a new clinical trial. According to a press release from the company, its study at The Feinstein Institutes for Medical Research has been given approval by the Institutional Review Board.
Tivic Health Reports Second Quarter 2023 Financial Results on August 14th Via Conference Call and Webcast
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the first quarter of 2023 via pre-recorded conference call and webcast on Monday, August 14th, 2023 at 1:30 pm PT / 4:30 pm ET. Teleconference Details: Toll-Free: 877-545-0523 International: 973-528-0016 Participant Access Code: 679005 Webcast Link https://www.webcaster.
Why Is Tivic Health Systems (TIVC) Stock Down 44% Today?
Tivic Health Systems (NASDAQ: TIVC ) stock is falling hard on Monday after the health technology company priced a public share offering. According to a press release, the company is offering up 33,173,000 shares of TIVC stock for a price of $0.041 per share.
Trading Penny Stocks With Limited Capital: 3 Tops Tips
The allure of penny stocks is undeniable. Their low price and potential for massive returns create an inviting landscape for individuals, especially those with limited capital, to take a leap into the world of investing.
Why Is Tivic Health Systems (TIVC) Stock Down 28% Today?
Tivic Health Systems (NASDAQ: TIVC ) stock is sliding lower on Tuesday after the company released its earnings report for the first quarter of 2023. That report starts with Tivic Health Systems revealing earnings per share of -11 cents in Q1.
TIVC Financial details
TIVC Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 18.26 | 37.34 | 33.38 | 19.02 | |
Net income per share | -180.35 | -177.01 | -243.15 | -104.37 | |
Operating cash flow per share | -159.57 | -131.43 | -160.65 | -92.21 | |
Free cash flow per share | -160.91 | -131.43 | -160.65 | -92.32 | |
Cash per share | 100.48 | 45.33 | 371.43 | 36.36 | |
Book value per share | 103.09 | -51.1 | 379.93 | 37.53 | |
Tangible book value per share | 103.09 | -51.1 | 379.93 | 37.53 | |
Share holders equity per share | 103.09 | -51.1 | 379.93 | 37.53 | |
Interest debt per share | 19.22 | 82.15 | 72.45 | 5.48 | |
Market cap | 11.94M | 11.95M | 13.55M | 6.19M | |
Enterprise value | 9.63M | 12.38M | 1.29M | 3.2M | |
P/E ratio | -2.88 | -2.93 | -1.6 | -0.61 | |
Price to sales ratio | 28.42 | 13.9 | 11.62 | 3.36 | |
POCF ratio | -3.25 | -3.95 | -2.42 | -0.69 | |
PFCF ratio | -3.23 | -3.95 | -2.42 | -0.69 | |
P/B Ratio | 5.03 | -10.16 | 1.02 | 1.71 | |
PTB ratio | 5.03 | -10.16 | 1.02 | 1.71 | |
EV to sales | 22.92 | 14.39 | 1.1 | 1.74 | |
Enterprise value over EBITDA | -2.66 | -3.89 | -0.24 | -0.32 | |
EV to operating cash flow | -2.62 | -4.09 | -0.23 | -0.36 | |
EV to free cash flow | -2.6 | -4.09 | -0.23 | -0.36 | |
Earnings yield | -0.35 | -0.34 | -0.63 | -1.63 | |
Free cash flow yield | -0.31 | -0.25 | -0.41 | -1.44 | |
Debt to equity | 0 | -1.25 | 0.05 | 0.15 | |
Debt to assets | 0 | 0.96 | 0.05 | 0.09 | |
Net debt to EBITDA | 0.64 | -0.13 | 2.25 | 0.3 | |
Current ratio | 4.55 | 1.17 | 11.72 | 2.84 | |
Interest coverage | -8.22 | -7.57 | -3.09 | -5.05M | |
Income quality | 0.88 | 0.83 | 0.66 | 0.88 | |
Dividend Yield | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 2.79 | 1.18 | 2.51 | 3.19 | |
Research and developement to revenue | 2.36 | 0.77 | 0.75 | 0.94 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.01 | 0 | 0 | 0 | |
Capex to revenue | -0.07 | 0 | 0 | -0.01 | |
Capex to depreciation | -7.75 | 0 | 0 | -0.06 | |
Stock based compensation to revenue | 0.02 | 0.09 | 0.05 | 0.22 | |
Graham number | 646.77 | 451.15 | 1.44K | 296.86 | |
ROIC | -1.54 | -12.29 | -0.38 | -2.15 | |
Return on tangible assets | -1.37 | -2.66 | -0.56 | -1.72 | |
Graham Net | 82.84 | -65.32 | 328.16 | 18.49 | |
Working capital | 2.32M | 222K | 13.07M | 3.43M | |
Tangible asset value | 2.37M | -1.18M | 13.27M | 3.63M | |
Net current asset value | 2.32M | -1.21M | 12.53M | 3.06M | |
Invested capital | 0 | -1.25 | 0.05 | 0.15 | |
Average receivables | 0 | 32.5K | 51.5K | 69.5K | |
Average payables | 0 | 369.5K | 579.5K | 1.06M | |
Average inventory | 0 | 358K | 335K | 646K | |
Days sales outstanding | 11.3 | 22.07 | 15.96 | 17.46 | |
Days payables outstanding | 189.96 | 124.47 | 222.38 | 313.36 | |
Days of inventory on hand | 244.53 | 81.07 | 120.92 | 204.41 | |
Receivables turnover | 32.31 | 16.54 | 22.86 | 20.91 | |
Payables turnover | 1.92 | 2.93 | 1.64 | 1.16 | |
Inventory turnover | 1.49 | 4.5 | 3.02 | 1.79 | |
ROE | -1.75 | 3.46 | -0.64 | -2.78 | |
Capex per share | -1.35 | 0 | 0 | -0.11 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.93 | 4.22 | 1.87 | 0.54 | 0.24 | |
Net income per share | -26.69 | -23.3 | -10.52 | -7.16 | -1.48 | |
Operating cash flow per share | -28.64 | -23.01 | -12.06 | -8.22 | -1.57 | |
Free cash flow per share | -28.69 | -22.96 | -12.52 | -8.3 | -1.57 | |
Cash per share | 65.54 | 36.34 | 25.68 | 8.96 | 4.34 | |
Book value per share | 59.64 | 37.51 | 25.87 | 10.65 | 4.85 | |
Tangible book value per share | 59.64 | 37.51 | 25.87 | 10.65 | 4.85 | |
Share holders equity per share | 59.64 | 37.51 | 25.87 | 10.65 | 4.85 | |
Interest debt per share | 5.93 | 5.47 | 2.51 | 1.55 | 0.35 | |
Market cap | 14.03M | 6.19M | 3.04M | 3.15M | 2.06M | |
Enterprise value | 8.28M | 3.21M | -1.62M | 946.84K | -2.7M | |
P/E ratio | -1.36 | -0.69 | -0.36 | -0.37 | -0.29 | |
Price to sales ratio | 29.42 | 15.18 | 8.08 | 19.54 | 7.3 | |
POCF ratio | -5.06 | -2.78 | -1.25 | -1.29 | -1.1 | |
PFCF ratio | -5.05 | -2.79 | -1.21 | -1.28 | -1.1 | |
P/B Ratio | 2.43 | 1.71 | 0.58 | 1 | 0.36 | |
PTB ratio | 2.43 | 1.71 | 0.58 | 1 | 0.36 | |
EV to sales | 17.35 | 7.86 | -4.32 | 5.88 | -9.56 | |
Enterprise value over EBITDA | -3.26 | -1.42 | 0.78 | -0.46 | 1.57 | |
EV to operating cash flow | -2.99 | -1.44 | 0.67 | -0.39 | 1.44 | |
EV to free cash flow | -2.98 | -1.44 | 0.64 | -0.38 | 1.44 | |
Earnings yield | -0.18 | -0.36 | -0.7 | -0.68 | -0.86 | |
Free cash flow yield | -0.2 | -0.36 | -0.83 | -0.78 | -0.91 | |
Debt to equity | 0.1 | 0.15 | 0.1 | 0.15 | 0.07 | |
Debt to assets | 0.07 | 0.09 | 0.07 | 0.1 | 0.06 | |
Net debt to EBITDA | 2.27 | 1.32 | 2.25 | 1.06 | 2.77 | |
Current ratio | 3.75 | 2.84 | 4.12 | 3.45 | 6.46 | |
Interest coverage | -2.58K | 2.26K | 0 | 0 | 0 | |
Income quality | 1.07 | 0.99 | 1.15 | 1.15 | 1.06 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 3.69 | 3.34 | 3.41 | 7.86 | 3.73 | |
Research and developement to revenue | 0.84 | 1.07 | 1.3 | 2.91 | 1.2 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0.04 | 0.01 | 0 | |
Capex to revenue | -0.01 | 0.01 | -0.25 | -0.15 | 0 | |
Capex to depreciation | -0.11 | 0.11 | -2.14 | -0.51 | 0 | |
Stock based compensation to revenue | 0.24 | 0.27 | 0.22 | 0.5 | 0.17 | |
Graham number | 189.25 | 140.23 | 78.23 | 41.42 | 12.7 | |
ROIC | -0.37 | -0.48 | -0.34 | -0.52 | -0.27 | |
Return on tangible assets | -0.31 | -0.39 | -0.3 | -0.46 | -0.25 | |
Graham Net | 45.04 | 18.48 | 18.81 | 5.82 | 3.77 | |
Working capital | 5.57M | 3.43M | 4.91M | 2.84M | 5.46M | |
Tangible asset value | 5.77M | 3.63M | 5.21M | 3.16M | 5.77M | |
Net current asset value | 5.16M | 3.06M | 4.59M | 2.57M | 5.21M | |
Invested capital | 0.1 | 0.15 | 0.1 | 0.15 | 0.07 | |
Average receivables | 93.5K | 91.5K | 72.5K | 35K | 72K | |
Average payables | 1.76M | 1.46M | 1.21M | 962.5K | 734.5K | |
Average inventory | 797K | 812K | 903K | 965.5K | 958K | |
Days sales outstanding | 17.92 | 19.41 | 13.64 | 7.27 | 41.81 | |
Days payables outstanding | 348.26 | 326.22 | 374.37 | 747.9 | 330 | |
Days of inventory on hand | 165.43 | 212.79 | 322.7 | 889.2 | 480 | |
Receivables turnover | 5.02 | 4.64 | 6.6 | 12.38 | 2.15 | |
Payables turnover | 0.26 | 0.28 | 0.24 | 0.12 | 0.27 | |
Inventory turnover | 0.54 | 0.42 | 0.28 | 0.1 | 0.19 | |
ROE | -0.45 | -0.62 | -0.41 | -0.67 | -0.31 | |
Capex per share | -0.05 | 0.05 | -0.47 | -0.08 | 0 |
TIVC Frequently Asked Questions
What is Tivic Health Systems, Inc. stock symbol ?
Tivic Health Systems, Inc. is a US stock , located in Hayward of Ca and trading under the symbol TIVC
What is Tivic Health Systems, Inc. stock quote today ?
Tivic Health Systems, Inc. stock price is $1.35 today.
Is Tivic Health Systems, Inc. stock public?
Yes, Tivic Health Systems, Inc. is a publicly traded company.